{"organizations": [], "uuid": "4b0562d3f01854ff97ccc73a4d8612c495cff2f7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-novartis-drug-afinitor-disperz-rec/brief-novartis-drug-afinitor-disperz-receives-fda-approval-to-treat-tsc-associated-partial-onset-seizures-idUSASC09VHM", "country": "US", "domain_rank": 408, "title": "BRIEF-Novartis Drug Afinitor Disperz Receives FDA Approval To Treat TSC-Associated Partial Onset Seizures", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-11T02:57:00.000+03:00", "replies_count": 0, "uuid": "4b0562d3f01854ff97ccc73a4d8612c495cff2f7"}, "author": "", "url": "https://www.reuters.com/article/brief-novartis-drug-afinitor-disperz-rec/brief-novartis-drug-afinitor-disperz-receives-fda-approval-to-treat-tsc-associated-partial-onset-seizures-idUSASC09VHM", "ord_in_thread": 0, "title": "BRIEF-Novartis Drug Afinitor Disperz Receives FDA Approval To Treat TSC-Associated Partial Onset Seizures", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "treat tsc-associated partial onset seizures reuters", "sentiment": "none"}, {"name": "novartis ag", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "novartis", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 10 (Reuters) - Novartis AG:\n* NOVARTIS DRUG AFINITOR DISPERZÂ® RECEIVES FDA APPROVAL TO TREAT TSC-ASSOCIATED PARTIAL - ONSET SEIZURES\n* AFINITOR DISPERZ RECEIVES FDA APPROVAL TO TREAT TSC-ASSOCIATED PARTIAL-ONSET SEIZURES Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-04-11T02:57:00.000+03:00", "crawled": "2018-04-11T04:15:17.014+03:00", "highlightTitle": ""}